Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral membrane fusion process is the stepwise merging of the viral envelope with a host cell membrane, permitting entry of the viral genome into the cytoplasm and initiating infection. This process is mediated by dedicated viral fusion proteins (glycoproteins embedded in the viral envelope), which undergo conformational rearrangements to catalyze fusion of the lipid bilayers. The mechanism, fundamental to all enveloped viruses, involves the engagement of a fusion peptide or fusion loop with the host membrane, followed by collapse of the fusion protein trimer to juxtapose viral and cellular membranes. This process is tightly regulated, can occur via various structural classes of fusion proteins (class I, II, III), and is an essential target for antiviral drug and vaccine development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral membrane fusion process.